×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

MPN

Kristie L. Kahl
After almost a decade with no new treatments, Inrebic offers patients with myelofibrosis new hope for the future.
Marilyn Fenichel
Collecting data about cancer through registries can help experts detect trends and patterns, leading to better care for patients.
Kristie L. Kahl
The Food and Drug Administration approved Inrebic as the first new treatment in nearly a decade for patients with myelofibrosis.
 
Kerry Fraser
During an interview with the “CURE Talks Cancer” podcast, retired NHL referee Kerry Fraser discussed what it is like going through treatment for essential thrombocythemia.
Kerry Fraser
Retired NHL referee Kerry Fraser explained how rest and exercise both factor into his “new normal” after receiving a diagnosis of essential thrombocythemia in 2017.
Kerry Fraser
Retired NHL referee Kerry Fraser shares his advice for coping with a new diagnosis after receiving his own in 2017.
Kristie L. Kahl
Treatment with fedratinib may lead to clinically meaningful responses among patients with myelofibrosis who were previously treated with Jakafi, according to an updated analysis of the phase 2 JAKARTA2 study.
Jessica Skarzynski
In this episode of CURE Talks Cancer, we talk with retired NHL referee Kerry Fraser about his MPN diagnosis, his advocacy work, and how he uses the lessons he learned on the ice and works with his winning team to conquer each day.
Judy Fazenbaker, Michael Herbert, Jeanne Mowry, Rose Ernst, Betty Hall and Joseph Herbert
A family collaborated on this essay to nominate registered oncology nurse Susan DeVictor for CURE®’s 2019 Extraordinary Healer® Award.
Jessica Skarzynski
Information about myeloproliferative neoplasms – or MPNs – is hard to come by. But the MPN Research Foundation’s myMPN Patient Registry aims to change that. Learn more about it in this week's episode of the CURE Talks Cancer podcast. 
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×